Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 3 2Phase 2 2Phase 1/2 1Phase 1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Adenocarcinoma of the Esophagogastric Junction 1

Interventions

Cisplatin 1038Cyclophosphamide 972Carboplatin 952Radiotherapy 890Bevacizumab 845Gemcitabine 817pembrolizumab 758Paclitaxel 738Docetaxel 733Oxaliplatin 704Capecitabine 646Fluorouracil 563Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 400Leucovorin 376Cytarabine 342Cetuximab 338Lenalidomide 326Trastuzumab 321Pemetrexed 314durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 277Temozolomide 275Prednisone 273

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × Endoscopy, Digestive System × Clear all
NCT06782048 2025-01-17

Use of Pyrvinium to Reverse Stomach Precancerous Conditions

National University Hospital, Singapore

Phase 2 Not yet recruiting
50 enrolled
Gastrointestinal

Stomach Neoplasms

NCT02287129 2023-11-28

MEMORI

Technical University of Munich

Phase 2 Completed
75 enrolled
Gastrointestinal

Adenocarcinoma of the Esophagogastric Junction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡